Saenz EV, Golibkhon A, Ibragim Y. A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease. Journal of Prevention, Diagnosis and Management of Human Diseases [Internet]. 2023 Jul. 5 [cited 2026 Feb. 16];3(02):1-8. Available from: https://hmjournals.com/journal/index.php/JPDMHD/article/view/2366